Table of contents
In this issue
p325 | doi:10.1038/nrd812
Editorial: Spotting winners in a wide field
p327 | doi:10.1038/nrd804
Research Highlights
Neurodegenerative diseases: The early results of misfolding
p329 | doi:10.1038/nrd798
High-throughput screening: Birds of a feather...
p330 | doi:10.1038/nrd799
Nuclear receptors: Blocking without obstruction
p330 | doi:10.1038/nrd808
Signalling pathways: Legless — but still the way forward
p331 | doi:10.1038/nrd807
Vascular disease: Getting the measure of stroke
p332 | doi:10.1038/nrd806
Computational chemistry: Getting focused
p332 | doi:10.1038/nrd811
Obesity: Exercising self-control
p333 | doi:10.1038/nrd809
In brief
Autoimmune disease | High-throughput screening | Cancer | Neurodegenerative disease
p333 | doi:10.1038/nrd813
Genomics: Look into the future
p334 | doi:10.1038/nrd800
Reviews
Combinatorial informatics in the post-genomics era
Dimitris K. Agrafiotis, Victor S. Lobanov & F. Raymond Salemme
p337 | doi:10.1038/nrd791
New therapeutics that modulate chemokine networks
Matthias K. Schwarz & Timothy N. C. Wells
p347 | doi:10.1038/nrd795
Cytochrome p450 enzymes in the generation of commercial products
F. Peter Guengerich
p359 | doi:10.1038/nrd792
Sod mimetics are coming of age
Daniela Salvemini, Dennis P. Riley & Salvatore Cuzzocrea
p367 | doi:10.1038/nrd796
Potential cardioprotective actions of no-releasing aspirin
John L. Wallace, Louis J. Ignarro & Stefano Fiorucci
p375 | doi:10.1038/nrd794
Telomere maintenance as a target for anticancer drug discovery
Stephen Neidle & Gary Parkinson
p383 | doi:10.1038/nrd793
Perspective
Timeline
New Safe Medicines Faster: a proposition for a pan-European research effort
Ole J. Bjerrum
p395 | doi:10.1038/nrd797
Careers and Recruitment
A bridge between academia and the drug discovery pipeline
Alan Gibson
p401 | doi:10.1038/nrd803
Correspondence
Correspondence: To the Editor of Nature Reviews Drug Discovery
Bernard Malfroy & Susan R. Doctrow
| doi:10.1038/nrd796-c1
Correspondence: In response to the letter of Malfroy and Doctrow
Daniela Salvemini, Salvatore Cuzzocrea & Dennis P. Riley
| doi:10.1038/nrd796-c2
